Page 40 - วารสารกรมการแพทย์แผนไทยฯ ปีที่ 18 ฉบับที่ 1
P. 40
30 วารสารการแพทย์แผนไทยและการแพทย์ ทางเลือก ปีที่ 18 ฉบับที่ 1 มกราคม-เมษายน 2563
3. Horneber M, Bueschel G, Dennert G, Less D, Ritter E, 10. Kucukoner M, Bilge Z, Isikdogan A, Kaplan MA, Inal A,
Zwahlen M. How many cancer patients use comple- Urakci Z. Complementary and alternative medicine usage
mentary and alternative medicine: A systematic re- in cancer patients in southeast of Turkey. Afr J Tradit
view and metaanalysis. Integrative Cancer Therapies. Complement Altern Med. 2012;10(1):21–5. Published 2012
2012;11(3):187-203. Oct 1. doi:10.4314/ajtcam.v10i1.4.
4. Johnson SB, Park HS, Gross CP, Yu JB. Use of alternative 11. Rashrash M, Schommer JC, Brown LM. Prevalence
medicine for cancer and its impact on survival. JNCI: and predictors of herbal medicine use among adults
Journal of the National Cancer Institute. 2018;110(1). in the United States. J Patient Exp. 2017;4(3):108–13.
5. Suedee N, Pongthavornkamol K, Sriyuktasuth A, Sirita- doi:10.1177/2374373517706612.
naratkul N. Symptom Experiences and Their Influences 12. Buckner CA, Lafrenie RM, Dénommée JA, Caswell JM,
on Functional Status in Hematological Malignancy Pa- Want DA. Complementary and alternative medicine use
tients Receiving Chemotherapy. Journal of Nursing in patients before and after a cancer diagnosis. Curr On-
Science. 2015. p. 29-40. (in Thai) col. 2018;25(4):e275–e281. doi:10.3747/co.25.3884.
6. Damery S, Gratus C, Grieve R, Warmington S, Jones J, 13. Dogu GG, Kargi A, Tanriverdi O, Yaren A, Demiray
Routledge P, Wilson S. The use of herbal medicines by G, Taskoylu BY, Ergin A. Complementary/alternative
people with cancer: a cross-sectional survey. Br J Cancer. medicine experience in cancer patients: a questionnaire-
2011;104(6):927-933. doi:10.1038/bjc.2011.47 based survey. International Journal of Hematology and
7. Farooqui M, Hassali MA, Shatar AK, Farooqui MA, Sal- Oncology. 2014;24(1);1-10. doi:10.4999/uhod.12008
eem F, Haq NU, Othman CN. (2016). Use of complemen- 14. Paul C, Carey M, Anderson A, Mackenzie L, Sanson-
tary and alternative medicines among Malaysian cancer Fisher R, Courtney R, Clinton-Mcharg T. Cancer patients’
patients: a descriptive study. J Tradit Complement Med. concerns regarding access to cancer care: perceived
2016;6(4):321-6. doi:10.1016/j.jtcme.2014.12.008 impact of waiting times along the diagnosis and treat-
8. Virani S, Bilheem S, Chansaard W, Chitapanarux I, ment journey. Eur J Cancer Care (Engl). 2012;21(3):321–9.
Daoprasert K, Khuanchana S, Leklob A, Pongnikorn D, doi:10.1111/j.1365-2354.2011.01311.x
Rozek LS, Siriarechakul S, Suwanrungruang K, Tas- 15. Edman JS, Roberts RS, Dusek JA, Dolor R, Wolever
sanasunthornwong S, Vatanasapt P, Sriplung H. National RQ, Abrams DI. Characteristics of cancer patients
and subnational population-based incidence of cancer in presenting to an integrative medicine practice-based
Thailand: assessing cancers with the highest burdens. research Network. Integr Cancer Ther. 2014;13(5):405-10.
Cancers (Basel). 2017;9(8). doi:10.3390/cancers9080108 doi: 10.1177/1534735414537876.
9. Puataweepong P, Sutheechet N, Ratanamongkol P. A 16. Stark L, Tofthagen C, Visovsky C, McMillan SC.
survey of complementary and alternative medicine use The Symptom Experience of Patients with Can-
in cancer patients treated with radiotherapy in Thailand. cer. J Hosp Palliat Nurs. 2012;14(1):61–70. doi:10.1097/
Evidence-based complementary and alternative medi- NJH.0b013e318236de5c.
cine. 2012;2012:670408.
